Chief Minister Prof. Dr. Manik Saha launched the Emicizumab for All Persons with Severe Haemophilia A in a programme at the Nursing College, AGDC and IGM Complex in Agartala. The initiative aims to expand access to treatment, with IGM Hospital serving as the nodal hospital.
Quick Glance
-
Tripura launched a programme to provide Emicizumab treatment for people with severe Haemophilia A.
-
IGM Hospital in Agartala will serve as the nodal hospital for the initiative.
-
The state government plans to strengthen district hospital infrastructure and improve access to specialised healthcare.
-
Chief Minister Dr. Manik Saha said patient referrals outside Tripura had declined by around 80%.
Tripura has launched a dedicated Emicizumab programme for people living with severe Haemophilia A. Chief Minister Prof. Dr. Manik Saha inaugurated the initiative at the Nursing College, AGDC and IGM Complex in Agartala.
The programme marks an important step in the state’s efforts to improve access to specialised medical care. It focuses on people with severe Haemophilia A, a genetic bleeding disorder that affects the blood’s ability to clot properly.
Emicizumab is a medicine used to prevent or reduce bleeding episodes in people with Haemophilia A. Its availability through a dedicated state programme could help eligible patients access specialised treatment.
During the launch, Dr. Saha highlighted the importance of the initiative. He also referred to his longstanding association with the Haemophilia Society.
The Chief Minister said several states, including Uttar Pradesh and Kerala, had already introduced Emicizumab treatment for haemophilia patients. Tripura’s programme forms part of the state’s broader effort to strengthen healthcare services.
However, the announcement did not specify the number of beneficiaries, the treatment schedule or the detailed eligibility criteria. The government also did not provide a separate timeline for extending Emicizumab services to district hospitals.
IGM Hospital to Coordinate the Programme
The state government has designated IGM Hospital in Agartala as the nodal hospital for the Emicizumab initiative.
This arrangement places the hospital at the centre of the programme’s implementation. It also provides a focal point for delivering specialised care to eligible patients.
Dr. Saha said extending Emicizumab availability to district hospitals would benefit people across Tripura. Such an expansion could make specialised treatment more accessible to patients who live far from Agartala.
The Chief Minister stressed that the government was prioritising improvements in healthcare delivery. He said the state was upgrading district hospital infrastructure to strengthen medical services.
Nevertheless, the announcement did not confirm when district hospitals would begin providing Emicizumab. Further details about the rollout would clarify how patients outside Agartala could access the treatment.
Tripura Strengthens District Hospital Infrastructure
Alongside the Emicizumab initiative, Dr. Saha outlined several ongoing healthcare projects across Tripura.
He said trauma care centres were operational in almost all district hospitals. Several hospitals had also introduced cardiac care centres.
These facilities aim to improve access to emergency and specialised medical services within the state. Better-equipped district hospitals can also reduce the need for patients to travel long distances for treatment.
The Chief Minister reiterated that referrals to hospitals outside Tripura had declined by approximately 80% compared with earlier years.
He described the reduction as an important indicator of improvements in the state’s healthcare system. However, he did not provide the baseline period or detailed figures behind the estimate.
The government is also developing additional medical infrastructure in Agartala. According to Dr. Saha, construction is underway on another building for the Dental College.
Agartala Government Medical College is also developing a dedicated hospital for mothers and children. In addition, the government is establishing drug rehabilitation centres in various districts.
Work on the Drug Rehabilitation Centre at Bishramganj is progressing rapidly, the Chief Minister said.
Government Highlights Healthcare Access in Remote Areas
Dr. Saha also highlighted efforts to improve medical services in remote parts of Tripura.
He cited Dhalai district as an example of the state’s healthcare progress. According to the Chief Minister, water-borne diseases previously caused frequent deaths in the district. He said the district no longer records deaths from such diseases.
The government is also working to ensure that people in remote areas can access medical services. These efforts complement the expansion of district hospital infrastructure and specialised treatment facilities.
The Chief Minister further said the state provides free vaccinations to patients suffering from breast cancer, oral cancer and other treatable cancers. He presented these measures as part of the government’s broader commitment to healthcare access.
The launch of the Emicizumab programme adds another specialised treatment initiative to this effort. Its reach will depend on implementation, access for eligible patients and the availability of treatment beyond the nodal hospital.
Health Department Secretary Kiran Gitte, Health Department Director Dr. Debashree Debbarma and other officials attended the launch programme.
People Also Ask
What is the Emicizumab programme in Tripura?
It is a state initiative launched to provide Emicizumab treatment for people with severe Haemophilia A. IGM Hospital in Agartala will serve as the nodal hospital.
Which hospital is the nodal centre for Emicizumab treatment in Tripura?
IGM Hospital in Agartala has been designated as the nodal hospital for the programme.
Will district hospitals in Tripura provide Emicizumab treatment?
Chief Minister Dr. Manik Saha said making Emicizumab available at district hospitals would benefit patients. However, the government has not announced a confirmed rollout schedule for those hospitals.
